Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients

References

• Bernal W, Jalan R, Quaglia A, et al. Acute-on-chronic liver failure. Lancet. 2015;386(10003):1576–1587.
   PubMed Web of Science ®Google Scholar
• Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2021, DOI: 10.1038/s41577-021-00549-4.
   PubMed Web of Science ®Google Scholar
• Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 2018;67(12):2181–2191.
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Triantafyllou E, Brenig R, et al. CD14+ CD15− HLA-DR− myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure. Gut. 2018;67(6):1155–1167.
   PubMed Web of Science ®Google Scholar
• Bernsmeier C, Pop OT, Singanayagan A, et al. Patients with acute on chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology. 2015 Mar;148(3):603–615.e14.
   PubMed Web of Science ®Google Scholar
• Korf H, du Plessis J, van Pelt J, et al. Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity. Gut. 2019;68(10):1872–1883.
   PubMed Web of Science ®Google Scholar
• Zhang J-Y, Zhang Z, Lin F, et al. Interleukin-17–Producing CD4 T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81–91.
   PubMed Web of Science ®Google Scholar
• Zhang IW, Curto A, López-Vicario C, et al. Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure. J Hepatol. 2021;76(1):93–106.
   PubMed Web of Science ®Google Scholar
• Li H, Xia Q, Zeng B, et al. Submassive hepatic necrosis distinguishes HBV-associated acute-on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol. 2015;63(1):50–59.
   PubMed Web of Science ®Google Scholar
• Richmond A. NF-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol. 2002;2(9):664–674.
   PubMed Web of Science ®Google Scholar
• Chen M, Reed RR, Lane AP. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell. 2019;25(4):501–513.e5.
   PubMed Web of Science ®Google Scholar
• Chena M, Xinga J, Pan D, et al. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-ĸB pathway. Biomed Pharmacother. 2020;128:110286.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF–ĸb, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–324.
   PubMed Web of Science ®Google Scholar
• Nikolaou K, Tsagaratou A, Eftychi C, et al. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer. Cancer Cell. 2012;21(6):738–750.
   PubMed Web of Science ®Google Scholar
• Urbanik T, Boger RJ, Longerich T, et al. Liver specific deletion of CYLD exon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. J Hepatol. 2012;57(5):995–1003.
   PubMed Web of Science ®Google Scholar
• Harhaj EW, Dixit VM. Deubiquitinases in the regulation of NF-κB signaling. Cell Res. 2011;21(1):22–39.
   PubMed Web of Science ®Google Scholar
• Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci. 2010;35(7):392–399.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Taraborrelli L, Walczak H. Linear ubiquitination in immunity. Immunol Rev. 2015;266(1):190–207.
   PubMed Web of Science ®Google Scholar
• Liu L, Jin R, Duan J, et al. Bioactive iron oxide nanoparticles suppress osteoclastogenesis and ovariectomy-induced bone loss through regulating the TRAF6-p62-CYLD signaling complex. Acta Biomater. 2020;103:281–292.
   PubMed Web of Science ®Google Scholar
• Bonaccia T, Emanuelea MJ. Dissenting degradation: deubiquitinases in cell cycle and cancer. Semin Cancer Biol. 2020;67(Pt 2):145–158.
   PubMed Web of Science ®Google Scholar
• Lim JH, Jono H, Komatsu K, et al. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt. Nat Commun. 2012;3:771.
   PubMed Web of Science ®Google Scholar
• Lim JH, Stirling B, Derry J, et al. Tumor suppressor CYLD regulates acute lung injury in lethal streptococcus pneumoniae infections. Immunity. 2007;27(2):349–360.
   PubMed Web of Science ®Google Scholar
• Yu B, Liu Z, Fu Y, et al. CYLD deubiquitinates nicotinamide adenine dinucleotide phosphate oxidase 4 contributing to adventitial remodeling. Arterioscler Thromb Vasc Biol. 2017;37(9):1698–1709.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang J, Yang Z, et al.; The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma. J Hepatol. 2014;60(5):975–984.
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091–1093.
   PubMed Web of Science ®Google Scholar
• Marra1 F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577–594.e1.
   PubMed Web of Science ®Google Scholar
• Triantafyllou E, Woollard KJ, McPhail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol. 2018;9:2948.
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Jaeschke H. The impact of sterile inflammation in acute liver injury. J Clin Transl Res. 2017;3(Suppl. 1):170–188.
   PubMedGoogle Scholar
• Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 2017;168(1-2):37–57.
   PubMed Web of Science ®Google Scholar
• Lork M, Verhelst K, Beyaert R. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different. Cell Death Differ. 2017;24(7):1172–1183.
   PubMed Web of Science ®Google Scholar
• Welte S, Urbanik T, Elßner C. Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma. PLoS One. 2014;9(10):e110591.
   PubMed Web of Science ®Google Scholar
• Ridder DA, Urbansky LL, Witzel HR, et al. Transforming growth factor-β activated kinase 1 (Tak1) Is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome. Cancers (Basel). 2022;14(2):430.
   PubMed Web of Science ®Google Scholar
• Trebicka J, Bork P, Krag A, et al. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure. Nat Rev Gastroenterol Hepatol. 2021;18(3):167–180.
   PubMed Web of Science ®Google Scholar
• Trebicka J, Macnaughtan J, Schnabl B, et al. The microbiota in cirrhosis and its role in hepatic decompensation. J Hepatol. 202;75(S1):S67–S81.
   PubMedGoogle Scholar
• Kumar A, Negi G, Sharma SS. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes, Obesity Metab. 2011;13(8):750–758.
   PubMed Web of Science ®Google Scholar
• Moreau R, Clària J, Aguilar F, et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. J Hepatol. 2020;72(4):688–701.
   PubMed Web of Science ®Google Scholar
• Li J, Liang X, Jiang J, et al. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF. Gut. 2022;71(1):1–13.
   PubMed Web of Science ®Google Scholar
• McPhail MJW, Shawcross DL, Lewis MR, et al. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis. J Hepatol. 2016;64(5):1058–1067.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382(22):2137–2145.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Moreau R, Kamath PS, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers. 2016;2:1604.
   Web of Science ®Google Scholar
• Clària J, Stauber RE, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology. 2016;64(4):1249–1264.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang W, Xu Y, et al. CYLD deubiquitinase negatively regulates high glucose-induced NF-B inflammatory signaling in mesangial cells. Biomed Res Int. 2017;2017:3982906.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Jono H, Kai H, et al. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 and TRAF7. J Biol Chem. 2005;280(49):41111–41121.
   PubMed Web of Science ®Google Scholar
• Hellerbrand C, Massoum R. Cylindromatosis – a protective molecule against liver diseases. Med Res Rev. 2016;36(2):342–359.
   PubMed Web of Science ®Google Scholar
• Pannem RR, Dorn C, Hellerbrand C, et al. Cylindromatosis gene CYLD regulates hepatocyte growth factor expression in hepatic stellate cells through interaction with histone deacetylase 7. Hepatology. 2014;60(3):1066–1081.
   PubMed Web of Science ®Google Scholar
• He F, Guo FC, Li Z, et al. Myeloid-specific disruption of recombination signal binding protein Jκ ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice. Hepatology. 2015;61(1):303–314.
   PubMed Web of Science ®Google Scholar
• Garg H, Sarin SK, Kumar M, et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011;53(3):774–780.
   PubMed Web of Science ®Google Scholar
• Zhou S-L, Yin D, Hu Z, et al. A positive feedback loop between cancer stem-like cells and tumor-associated neutrophils controls hepatocellular carcinoma progression. Hepatology. 2019;70(4):1214–1230.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13(3):131–149.
   PubMed Web of Science ®Google Scholar